News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Barbier Ann
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Barbier Ann (Chief Medical Officer) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 70,000 options to buy
@ $23.82, valued at
$1.7M
|
|
| 06/25/2020 |
4
| Barbier Ann (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $3.27, valued at
$130.8k
|
|
| 03/05/2020 |
4
| Barbier Ann (Chief Medical Officer) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 150,000 options to buy
@ $7.66, valued at
$1.1M
|
|
| 01/28/2020 |
4
| Barbier Ann (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $3.23, valued at
$64.6k
|
|
| 03/12/2019 |
4
| Barbier Ann (Chief Medical Officer) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 125,000 options to buy
@ $7.95, valued at
$993.8k
|
|
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2018 |
4
| Barbier Ann (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $6.43, valued at
$192.9k
|
|
|
|